Filing Details
- Accession Number:
- 0001127602-25-020282
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-08 16:18:55
- Reporting Period:
- 2025-08-07
- Filing Date:
- 2025-08-08
- Accepted Time:
- 2025-08-08 16:18:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767215 | W Joseph Laplume | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Evp, Corp Strategy & Develop | No | Yes | No | No |
Transaction Summary
Sold: | 400 shares | Avg. Price: $150.04 | Total Value: $60,016.00 |
Number of Shares After Transactions: | 24,916 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-08-07 | 400 | $150.04 | 24,916 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |